Related Experiment Video
Updated: Jul 15, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Cytomegalovirus (CMV) resistance to antivirals
1Department of Laboratory Medicine, UCSF Mt. Zion Medical Center, San Francisco, CA, USA. Lawrence.Drew@clinlab.ucsfmedctr.org
Abstract:
This article reviews the biology of cytomegalovirus (CMV), the approved antiviral therapies, and mechanisms of resistance to these drugs. The rates of resistance development in clinical trials are presented, as are the assays for testing susceptibility by phenotypic and genotypic methods. Factors that favor the development of clinical and in vitro antiviral resistance are discussed. Finally, approaches to altering antiviral therapy as resistance develops are outlined.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Treatment Resistant Cancers
Mechanism of Antibiotic Resistance in MRSA
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Antiviral Nucleoside Inhibitors

